9:22 AM
Leo Group India
| ||
| Valeant Pharmaceuticals To Syndicate Incremental Loans Stockhouse The incremental term B loans will be used to provide a portion of the financing for Valeant's anticipated acquisition of all of the outstanding common stock of Medicis Pharmaceutical Corporation (NYSE: MRX). The incremental term B loans will have a ... See all stories on this topic » | ||
| NovaBay Pharmaceuticals (NBY) Announces Expansion of Strategic Marketing ... NASDAQ NovaBay Pharmaceuticals (NBY) Announces Expansion of Strategic Marketing Agreement for NeutroPhase(R) in Southeast Asia. NovaBay to Receive Up to $700,000 in Upfront and Milestone Payments. Agreement Includes Equity Investment by Naqu Area ... See all stories on this topic » | ||
| Bayer HealthCare to Acquire US Animal Health Business From Teva ... The Herald | HeraldOnline.com JERUSALEM — Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that they have signed an agreement in which Bayer will acquire the U.S. based animal health business of Teva for up to 145 million USD. See all stories on this topic » | ||
| Aoxing Pharmaceutical Company, Inc. Declines To Comment On Market Activity Sacramento Bee In view of the unusual activity today in the market for the common stock of Aoxing Pharmaceutical Company, Inc., the NYSE Euronext has contacted the company in accordance with the Exchange's usual practice. The company stated that its policy is not to ... See all stories on this topic » | ||
| Govt to appoint new authority for certifying quality of APIs Hindu Business Line The Health Ministry held a meeting with the drug regulator, Pharmaceutical Export Promotion Council of India (Pharmexcil), and trade bodies earlier this week on the issue. "The Government will appoint the required competent authority in two weeks time. See all stories on this topic » | ||
| Research and Markets: Lebanon Pharmaceuticals and Healthcare Report Q3 2012 The Herald | HeraldOnline.com The Lebanon Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence ... See all stories on this topic » | ||
| SciClone Pharmaceuticals CEO of China operations to resign Equities.com "All of us have enjoyed working in partnership with Mark on the successful integration of NovaMed into SciClone and on helping our combined Company to strengthen its standing in the top echelon of China pharmaceutical companies. Mark has had a long ... See all stories on this topic » | ||
| Most Read Pharmaceutical and Health Condition News - August '12 IT News Online AUSTIN, Texas, Sept. 14, 2012 /PRNewswire/ -- dailyRx, Inc., a leading digital publisher, announced today the top five health conditions and medications viewed on the dailyRx News Network™ during August 2012. dailyRx News is syndicated to various ... See all stories on this topic » | ||
| Pfizer and Hisun launch Hisun-Pfizer Pharmaceuticals venture Zenopa The new venture will specialise in high-quality and low-cost branded generic medicines - one of the fastest-growing segments in the global pharmaceutical industry - and will serve both the Chinese and global markets. This alliance takes advantage of ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment